Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHS2404150	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs(4)	Generic Drug	2024-12-03		Ningbo Krka Menovo Pharmaceutical Co Ltd;Ningbo Menovo TianKang Pharmaceutical Co Ltd			view
JYHZ2300307	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	License Renew	2023-07-15		Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYHZ2300308	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	License Renew	2023-07-15		Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG			view
JYHB2001001	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2020-07-03	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2020-08-21	view
JYHB2000799	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2020-06-19	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2020-07-07	view
JYHB2000705	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2020-06-04	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	Filed	2020-06-16	view
JYHB2000467	二甲双胍恩格列净片（Ⅳ）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2020-04-22	勃林格殷格翰（中国）投资有限公司	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	Certificate Issued	2020-05-14	view